Uniting TCE Leaders to Optimise Target Selection & Innovate Cell Engager Design to Accelerate Transformative Immunotherapies from Research Towards Clinical Approval.
Returning to London in December 2026, the 2nd T-Cell Engager Therapeutics Summit Europe will bring together industry pioneers and leading experts to showcase the latest advances in target selection technologies, innovative engager designs and strategies for overcoming safety challenges. Across 3 jam-packed days, attendees will gain data-driven insights into accelerating the development of T-cell engager therapeutics across both oncology and autoimmune disease landscapes.
View Event
